Jonathan Goodall

Jonathan Goodall possesses extensive experience in the pharmaceutical industry, with a focus on pricing and market access strategies. Goodall began a career as a Research Associate at Novexin from 2003 to 2005, followed by a series of roles at AstraZeneca from 2008 to the present, including Director positions in Global Pricing, Reimbursement, and Access across various therapeutic areas such as antibiotics and autoimmune diseases. Notable contributions include the development of pricing strategies for AstraZeneca's global brands and leading market access initiatives in the Asia-Pacific and American regions. Additionally, Goodall’s earlier experience includes working as an Analyst at Global Insight and a Postdoctoral Research Associate at Basilea Pharmaceutica. Educational qualifications include a Ph.D. in Biochemistry and a Bachelor's degree in Biochemistry, both obtained from The University of Birmingham.